DNA microarray to analyze adenovirus-host interactions

Stefania Piersanti1, Enrico Tagliafico, Isabella Saggio

  • 1Dipartimento di Biologia e Biotecnologie, Sapienza, Università di Roma, Roma, Italy.

Insights

Gene chips identify molecular toxicity of viral vectors, revealing cell cycle changes and immune responses. This protocol aids safe clinical applications of gene therapy vectors.

Area of Science:

  • Molecular Biology
  • Toxicology
  • Gene Therapy

Background:

  • Assessing viral vector molecular toxicity is crucial for safe human clinical trials.
  • DNA chips (gene chips) enable high-throughput analysis of transduced cell profiles.
  • Previous studies utilized gene chips to identify vector-specific toxicities.

Purpose of the Study:

  • To detail a protocol for using gene chips to analyze the toxicogenomic signature of helper-dependent adenoviral vectors.
  • To provide guidelines applicable to various experimental contexts involving viral vector toxicity.
  • To highlight the importance of in silico data analysis for interpreting gene chip results.

Main Methods:

  • Utilized DNA chips (gene chips) for high-throughput evaluation of transduced cell profiles.
  • Applied the protocol to study human and canine helper-dependent adenoviral vectors.
  • Included detailed procedures for in silico elaboration of gene chip raw data.

Main Results:

  • Identified vector-specific properties, including cell cycle alterations induced by vector genomic DNA.
  • Detected activation of specific innate immune pathways attributable to viral particles.
  • Demonstrated the utility of gene chips in dissecting viral vector toxicogenomic signatures.

Conclusions:

  • Gene chips are effective tools for defining the molecular toxicity of viral vectors.
  • The described protocol facilitates the study of adenoviral vector toxicity.
  • This approach supports the safe clinical translation of gene therapy vectors.